Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia
City of Hope Medical Center
City of Hope Medical Center
Beijing GoBroad Hospital
City of Hope Medical Center
Chulalongkorn University
Children's Hospital Medical Center, Cincinnati
OHSU Knight Cancer Institute
Dana-Farber Cancer Institute
University of California, San Francisco
British Columbia Cancer Agency
City of Hope Medical Center
Bambino Gesù Hospital and Research Institute
University of Colorado, Denver
Baylor College of Medicine
University of Arizona
Dana-Farber Cancer Institute
Medical College of Wisconsin
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
Vinmec Research Institute of Stem Cell and Gene Technology
Memorial Sloan Kettering Cancer Center
The First Affiliated Hospital with Nanjing Medical University
Stanford University
Institute of Hematology & Blood Diseases Hospital, China
Stanford University
Shanghai Tongji Hospital, Tongji University School of Medicine
Memorial Sloan Kettering Cancer Center
Ohio State University Comprehensive Cancer Center
Thomas Jefferson University
City of Hope Medical Center
University of Kansas Medical Center
Fifth Affiliated Hospital, Sun Yat-Sen University
Cedars-Sinai Medical Center
Calibr, a division of Scripps Research
Belarusian Research Center for Pediatric Oncology, Hematology and Immunology
Calibr, a division of Scripps Research
Fred Hutchinson Cancer Center
Stanford University
Fred Hutchinson Cancer Center
Stanford University
M.D. Anderson Cancer Center
University of Virginia
University of Washington
University of Pennsylvania
Shanghai Pudong Hospital
Seoul National University Hospital
Loyola University
Zhejiang University
Cancer Research UK
Shenzhen Geno-Immune Medical Institute
M.D. Anderson Cancer Center